Edwards Lifesciences (EW) returns
Edwards Lifesciences returns over 10 years
$1,000 invested in Edwards Lifesciences ten years ago was worth $2,871 at the close on October 30, 2026, with dividends reinvested: an average return of 11.1% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +6.6% | — | $1,066 | -0.9% |
| 3 months | +5.9% | — | $1,059 | +2.1% |
| Year to date | +7.9% | — | $1,079 | +11.7% |
| 1 year | +10.2% | — | $1,102 | +12.4% |
| 3 years | +47.5% | +13.8% | $1,475 | +88.5% |
| 5 years | -23.2% | -5.1% | $767.90 | +76.0% |
| 10 years | +187.1% | +11.1% | $2,871 | +316.6% |
Edwards Lifesciences return by calendar year
| Year | EW | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +7.9% | +11.7% | -3.8% |
| 2025 | +15.2% | +17.7% | -2.6% |
| 2024 | -2.9% | +24.9% | -27.8% |
| 2023 | +2.2% | +26.2% | -24.0% |
| 2022 | -42.4% | -18.2% | -24.2% |
| 2021 | +42.0% | +28.7% | +13.3% |
| 2020 | +17.3% | +18.4% | -1.1% |
| 2019 | +52.3% | +31.2% | +21.1% |
| 2018 | +35.9% | -4.6% | +40.5% |
| 2017 | +20.3% | +21.7% | -1.4% |
| 2016 | +18.6% | +12.0% | +6.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: EW financials · EW valuation
No forecast, no recommendation. This page describes Edwards Lifesciences from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.